Huober J, Fasching P, Paepke S. et al
Letrozole in combination with trastuzumab is superior to letrozole monotherapy as first line treatment in patients with hormone-receptor-positive, HER2-positive metastatic breast cancer (MBC) – results of the eLEcTRA trial.
Cancer Res 2009;
69 (24, suppl) ;doi:
Download Bibliographical Data